Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.
Explore this paper's citation graph
Summary
If autografting with PBPCs in malignant lymphoma with poor prognosis is being considered, mobilization and harvesting should be planned early after initial diagnosis to avoid exhaustion of hematopoiesis by cumulative toxicity.
- Type
- article
- Published
- 1994-06-15
- Cited by
- 519
- References
- 26
- Access
- Open access
- OpenAlex
- https://openalex.org/W92846538
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7785081
Keywords
Medicine, Leukapheresis, Chemotherapy, Gastroenterology, CD34
References
- Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
- Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.
- Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
- Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
- Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor.
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.
- Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
- Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies.
- The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow.
- Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.
- A comparison between 4 GM/M2 and 7 GM/M2 cyclophosphamide for peripheral blood stem cell mobilization
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
- Cell-dose effect in circulating stem-cell autografting.
- GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen.
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
- Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.
- Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation.
- The role of conditioning regimens in homing of transplanted hemopoietic cells.
- Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice.
- Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Cited by
- High‐dose therapy with peripheral blood progenitor cell support in patients with non‐hodgkin's lymphoma
- Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation
- Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
- Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony‐stimulating factor in mouse strains with distinct marrow‐cell pool sizes
- Peripheral Blood Stem Cell Mobilization with Cyclophosphamide in Combination with G-CSF, GM-CSF, or Sequential GM-CSF/G-CSF in Non-Hodgkin's Lymphoma Patients: A Randomized Prospective Study
- Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cellsin two automated leukapheresis systems
- The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative
- High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.
- Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma
- Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
- Plerixafor Enables Successful Hematopoietic Stem Cell Collection in an Extensively Pretreated Patient with Testicular Cancer
- Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
- Single Dose Preemptive Plerixafor for Stem Cell Mobilization for ASCT After Lenalidomide Based Therapy in Multiple Myeloma: Impact in Resource Limited Setting
- Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transfer.
- Intensive therapies in follicular non-Hodgkin lymphomas.
- Mobilization of allogeneic peripheral blood progenitor cells.
- Mobilization and selection of CD34+ cells.
- Evaluation de la qualité des soins : approche par indicateur dans les centres européens de greffe de cellules souches hématopoïétiques accrédités JACIE
- Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity
- Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
Related papers
- Estimation of the Progenitor Cell Yield in a Leukapheresis Product by Previous Measurement of CD34+ Cells in the Peripheral Blood
- Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution
- Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation.
- Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant
- In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
- A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation
- RhG-CSF Mobilized and Apheresis-Collected Endothelial Progenitor Cells for Therapeutic Vasculogenesis.
- Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
- Plastic-adherent progenitor cells in mobilized peripheral blood progenitor cell collections.
- Morphological and functional characteristics of short‐term and long‐term bone marrow cultures in chronic myelogenous leukemia